YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Novartis AG announced it would purchase Endocyte Inc. for $2.1 billion.
The acquisition would give the Swiss pharmaceutical company access to Endocyte's so-called radiopharmaceuticals, which carry radioactive substances to kill tumor cells.
Endocyte is currently developing a new treatment for prostate cancer.
Read more from The Wall Street Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects